Related Experiment Video

Updated: Dec 21, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.3K

Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration - United States, 2020

Jeanne M Santoli, Megan C Lindley, Malini B DeSilva

    MMWR. Morbidity and Mortality Weekly Report
    |May 15, 2020
    PubMed

    Insights

    The COVID-19 pandemic disrupted routine healthcare, including essential childhood immunizations. The Centers for Disease Control and Prevention (CDC) issued guidance to ensure children receive timely vaccinations.

    Area of Science:

    • Public Health
    • Epidemiology
    • Pediatrics

    Background:

    • The COVID-19 pandemic declared a national emergency in March 2020 led to widespread disruptions in healthcare delivery across the U.S.
    • Stay-at-home orders and limitations on non-essential activities impacted the accessibility of routine preventive care for children.
    • Early in the pandemic, confirmed cases were reported in all 50 states, highlighting the urgent need for public health interventions.

    Purpose of the Study:

    • To highlight the critical importance of maintaining routine well-child care and immunization schedules during the COVID-19 pandemic.
    • To emphasize the specific need for timely vaccinations in children aged 24 months and younger, a key period for childhood immunizations.
    • To inform healthcare providers and parents about the necessity of continuing essential pediatric care despite public health emergencies.

    Main Methods:

    • Review of public health declarations and state-level mandates related to the COVID-19 pandemic.
    • Analysis of guidance issued by the Centers for Disease Control and Prevention (CDC) regarding pediatric preventive care.
    • Examination of the timing of vaccine recommendations for children up to 24 months of age.

    Main Results:

    • The declaration of a national emergency and subsequent public health measures created significant challenges for healthcare systems.
    • Guidance from the CDC underscored the continued necessity of well-child visits and immunizations.
    • The period up to 24 months is critical for administering a substantial number of recommended childhood vaccines.

    Conclusions:

    • Maintaining routine pediatric care, especially immunizations, is crucial for public health during pandemics.
    • Healthcare providers must adapt to ensure continuity of essential services like childhood vaccinations.
    • Public health messaging is vital to encourage adherence to vaccination schedules amidst widespread disruptions.

    More Related Videos

    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen07:44

    Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

    Published on: May 12, 2023

    1.5K
    Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses03:53

    Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

    Published on: November 10, 2023

    1.7K

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    148
    Vaccinations01:51

    Vaccinations

    Overview
    50.9K
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
    172
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
    190
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    169
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
    130